Clinical Trials Browser

Phase 1 × camrelizumab × Gynecologic × Clear all

NCT04508686 2021-01-29

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Phase 1 Unknown

Advanced Cervical Cancer